| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.41 | 0.006 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |